Neogen Chemicals shares hit a new high of Rs 2,140, as it rallied 13 per cent on the BSE in Thursday’s intra-day trade on favourable demand outlook.
The stock of the specialty chemicals maker is trading higher for the sixth straight day, surging 40 per cent during the period. In the past two weeks, the stock has zoomed 46 per cent.
The stock of the specialty chemicals maker is trading higher for the sixth straight day, surging 40 per cent during the period. In the past two weeks, the stock has zoomed 46 per cent.
Neogen Chemicals is engaged in the business of manufacturing eco-friendly specialty chemicals that are used in pharmaceutical, engineering and agro-chemical (agchem) industries. Neogen has developed significant expertise in the highly demanding field of Bromine Compounds, Lithium compounds, and more recently, advanced intermediates for pharmaceutical industries and pesticides industries.
The company's management remains optimistic about the long-term structural growth of the chemicals sector, driven by the China free/ China+1 strategy; focus on reducing chemical imports, robust R&D capabilities, and favourable government policies.
Moreover, India offers a strong alternative with its scale, technology, raw materials, and supportive reforms as global chemical companies seek to diversify their production bases. India’s chemical sector is well-positioned to benefit from this shift and capture a significant market share.
Moreover, India offers a strong alternative with its scale, technology, raw materials, and supportive reforms as global chemical companies seek to diversify their production bases. India’s chemical sector is well-positioned to benefit from this shift and capture a significant market share.
To mitigate current ag-chem market challenges in the existing business, the management said the company is looking at non-ag-chem opportunities until the global agro-chemical market recovers, and they remain confident of achieving Rs 900-1,000 crore in revenues in FY26, based on anticipated recovery in the latter half of this financial year.
Further, government incentives like ‘Make in India’ and PLI Scheme are also expected to propel the company’s growth, particularly in pharmaceutical intermediates and lithium-ion batteries for electric vehicles (EVs) and renewable energy storage.
Neogen aims to consolidate its position as a trusted business partner by maintaining consistent product quality and ensuring timely supply, ultimately establishing itself as India’s primary provider of electrolytes for EV applications.
Neogen aims to consolidate its position as a trusted business partner by maintaining consistent product quality and ensuring timely supply, ultimately establishing itself as India’s primary provider of electrolytes for EV applications.
Demand for electrolytes and lithium salts in India and global markets remains promising, driven by the need for a secure and diversified supply chain.
This represents a potential opportunity for Neogen Ionics to enhance the installation of lithium salt capacities to support the burgeoning demand, the company said in its FY24 annual report.
This represents a potential opportunity for Neogen Ionics to enhance the installation of lithium salt capacities to support the burgeoning demand, the company said in its FY24 annual report.
In addition to the PLI advantage, there are additional 7 to 8 non PLI players, who have also announced significant battery capacities to come online over the next three years.
For salts as well, the demand for non-Chinese lithium salts remains strong and is projected to grow at a healthy pace by 2030. At present, there are only 2-3 active manufacturers of Lithium Electrolyte Salts outside China, the company said.
For salts as well, the demand for non-Chinese lithium salts remains strong and is projected to grow at a healthy pace by 2030. At present, there are only 2-3 active manufacturers of Lithium Electrolyte Salts outside China, the company said.